世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3976 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・去勢抵抗性前立腺がん治療の市場動向 ・企業の競争状況、市場シェア ・去勢抵抗性前立腺がん治療の種類別市場規模と予測2016-2027（化学療法、ホルモン療法、免疫療法、放射線療法） ・去勢抵抗性前立腺がん治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・去勢抵抗性前立腺がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・去勢抵抗性前立腺がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・去勢抵抗性前立腺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・去勢抵抗性前立腺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・去勢抵抗性前立腺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Johnson & Johnson Services, Inc.、Pfizer, Inc.、Astellas Pharma, Inc.、Bayer AG） ・結論

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC.

Market Analysis and Insights: Global Castrate-resistant Prostate Cancer Treatment Market
The global Castrate-resistant Prostate Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Castrate-resistant Prostate Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Castrate-resistant Prostate Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Castrate-resistant Prostate Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Castrate-resistant Prostate Cancer Treatment market.

Global Castrate-resistant Prostate Cancer Treatment Scope and Market Size
Castrate-resistant Prostate Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Castrate-resistant Prostate Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiotherapy

Segment by Application
Hospital
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Astellas Pharma, Inc.
Bayer AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Hormonal Therapy
1.2.4 Immunotherapy
1.2.5 Radiotherapy
1.3 Market by Application
1.3.1 Global Castrate-resistant Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Castrate-resistant Prostate Cancer Treatment Market Perspective (2016-2027)
2.2 Castrate-resistant Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Castrate-resistant Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Castrate-resistant Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Castrate-resistant Prostate Cancer Treatment Industry Dynamic
2.3.1 Castrate-resistant Prostate Cancer Treatment Market Trends
2.3.2 Castrate-resistant Prostate Cancer Treatment Market Drivers
2.3.3 Castrate-resistant Prostate Cancer Treatment Market Challenges
2.3.4 Castrate-resistant Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Castrate-resistant Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Castrate-resistant Prostate Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Castrate-resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Castrate-resistant Prostate Cancer Treatment Revenue
3.4 Global Castrate-resistant Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Castrate-resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Castrate-resistant Prostate Cancer Treatment Revenue in 2020
3.5 Castrate-resistant Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Castrate-resistant Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Castrate-resistant Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Castrate-resistant Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Castrate-resistant Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Castrate-resistant Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Castrate-resistant Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Castrate-resistant Prostate Cancer Treatment Market Size (2016-2027)
6.2 North America Castrate-resistant Prostate Cancer Treatment Market Size by Type
6.2.1 North America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Castrate-resistant Prostate Cancer Treatment Market Size by Application
6.3.1 North America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Castrate-resistant Prostate Cancer Treatment Market Size by Country
6.4.1 North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Castrate-resistant Prostate Cancer Treatment Market Size (2016-2027)
7.2 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Castrate-resistant Prostate Cancer Treatment Market Size (2016-2027)
9.2 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Castrate-resistant Prostate Cancer Treatment Introduction
11.1.4 Sanofi Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Details
11.2.2 Johnson & Johnson Services, Inc. Business Overview
11.2.3 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Introduction
11.2.4 Johnson & Johnson Services, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Services, Inc. Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
11.3.5 Pfizer, Inc. Recent Development
11.4 Astellas Pharma, Inc.
11.4.1 Astellas Pharma, Inc. Company Details
11.4.2 Astellas Pharma, Inc. Business Overview
11.4.3 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Introduction
11.4.4 Astellas Pharma, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
11.4.5 Astellas Pharma, Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Castrate-resistant Prostate Cancer Treatment Introduction
11.5.4 Bayer AG Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
11.5.5 Bayer AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormonal Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Radiotherapy
Table 6. Global Castrate-resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Castrate-resistant Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Castrate-resistant Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Castrate-resistant Prostate Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Castrate-resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Castrate-resistant Prostate Cancer Treatment Market Trends
Table 13. Castrate-resistant Prostate Cancer Treatment Market Drivers
Table 14. Castrate-resistant Prostate Cancer Treatment Market Challenges
Table 15. Castrate-resistant Prostate Cancer Treatment Market Restraints
Table 16. Global Castrate-resistant Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Castrate-resistant Prostate Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Castrate-resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castrate-resistant Prostate Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Castrate-resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Castrate-resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Castrate-resistant Prostate Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Castrate-resistant Prostate Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Castrate-resistant Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Castrate-resistant Prostate Cancer Treatment Product
Table 66. Sanofi Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Johnson & Johnson Services, Inc. Company Details
Table 69. Johnson & Johnson Services, Inc. Business Overview
Table 70. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Product
Table 71. Johnson & Johnson Services, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Services, Inc. Recent Development
Table 73. Pfizer, Inc. Company Details
Table 74. Pfizer, Inc. Business Overview
Table 75. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Product
Table 76. Pfizer, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer, Inc. Recent Development
Table 78. Astellas Pharma, Inc. Company Details
Table 79. Astellas Pharma, Inc. Business Overview
Table 80. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Product
Table 81. Astellas Pharma, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Astellas Pharma, Inc. Recent Development
Table 83. Bayer AG Company Details
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Castrate-resistant Prostate Cancer Treatment Product
Table 86. Bayer AG Revenue in Castrate-resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Bayer AG Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castrate-resistant Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Hormonal Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Radiotherapy Features
Figure 6. Global Castrate-resistant Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Castrate-resistant Prostate Cancer Treatment Report Years Considered
Figure 11. Global Castrate-resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Castrate-resistant Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Castrate-resistant Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Castrate-resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Figure 15. Global Castrate-resistant Prostate Cancer Treatment Market Share by Players in 2020
Figure 16. Global Top Castrate-resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castrate-resistant Prostate Cancer Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Castrate-resistant Prostate Cancer Treatment Revenue in 2020
Figure 18. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Castrate-resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 22. North America Castrate-resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 23. North America Castrate-resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 24. United States Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Castrate-resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 28. Europe Castrate-resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 29. Europe Castrate-resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 30. Germany Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Share by Region (2016-2027)
Figure 40. China Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Castrate-resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Castrate-resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Castrate-resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Services, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
Figure 61. Pfizer, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
Figure 62. Astellas Pharma, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
Figure 63. Bayer AG Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---